ImmunoGen, Inc.
IMGN
NASDAQ4.75
IMGN
Has a PDUFA date of Nov 28 2022. This means they will get a response from the FDA on accelerated drug approval on or before that date. This current drug trial was setup based on FDA working directly with the company when they did not approve 2 or 3 years ago so the chances of approval are better than most drugs waiting on approval.
drug name: Mirvetuximab soravtansine
IMGN's first approved drug was given away to Genentech for cheap called trastuzumab
IMGN has a very high institutional ownership representing ~90% of float with short interest of about 13million shares
IMGN very good today
don't fall in love with a stock. I'm still in it. fell in love with IMGN. bought 10k shares. have held it for 30 years
User Report| | | | :--|:--|:--|:-- Total Submissions|7|First Seen In WSB|1 year ago Total Comments|94|Previous DD|x Account Age|2 years|[^scan ^comment ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_comment&message=Replace%20this%20text%20with%20a%20comment%20ID%20(which%20looks%20like%20h26cq3k)%20to%20have%20the%20bot%20scan%20your%20comment%20and%20correct%20your%20first%20seen%20date.)|[^scan ^submission ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_submission&message=Replace%20this%20text%20with%20a%20submission%20ID%20(which%20looks%20like%20h26cq3k)%20to%20have%20the%20bot%20scan%20your%20submission%20and%20correct%20your%20first%20seen%20date.) Vote Spam (NEW)|Click to Vote|Vote Approve (NEW)|Click to Vote
IMGN 😍💵
why is imgn flying
User Report| | | | :--|:--|:--|:-- Total Submissions|6|First Seen In WSB|1 year ago Total Comments|38|Previous DD|x Account Age|1 year|^scan ^comment |^scan ^submission
Problem is IMGN and GTBP are doing similar no? They’re also further along and have better teams 🤷♂️
Yes, it's possible. My trading group has done it many times. The problem right now is that extremely high valuations, panic over inflation, and Chinese manipulation of metals (among other things) has created an environment where upside potential is low, and downside potential is huge. Swing trading with common shares isn't the best way to try to make money in these market conditions. Options trading gives you far greater control and safety. But, in general, the shorter the time frame, the more risk that you need to take on.
For example, last Thursday, we did something that we call the Jamazon strategy. In nine minutes, I booked $505.29 on an AMZN option play. I repeated this twice, yesterday, to add $396. The Jamazon is a high-risk, extremely short-term strategy that I wouldn't advise for most people. (You need to be intimately familiar with macroeconomics, AMZN's minute price action, understand how to discern price action possibilities from technical analysis, and have impeccable timing, with superb execution skills.)
We've done Jamazons by collecting data and analyzing descriptive statistics to design the actual play. Most people probably wouldn't want to do the level of planning work that we go through, for a relatively small reward, but it always feels good to win. Also, never underestimate the power of luck.
If you insist on swing trading common shares, if my life depended on it, I would advise you to try IMGN right now. (I wouldn't normally recommend a pre-profitable small-cap company in these market conditions, but this one looks to be a rare, undiscovered stock with a margin of safety from patent sales and a strong pipeline, with a powerful near-term catalyst.) It moves slowly, even pleasingly, so there aren't any sudden and dramatic surprises. It has a very powerful catalyst toward the end of September: the release of (positive) Phase III results for a very specific form of ovarian cancer. We're getting strong signs that we're going to see good news, and that the share price will fly. Now is the best time to get in, but realize that the price could drift down to about $5.75/share again. I've been steadily accumulating shares, and have shorted PUTs on it that strike at $5.00/share and $6.00/share, and expire in October.
I know that 2.5 months is longer than you want to wait, but the shorter the time period, the less you're making a strong bet, and the more you're gambling, usually. Most of the time, that doesn't end well for the trader.
The fact is that the market conditions are very challenging. If you do want to swing trade, you need to do it within the three week periods after the monthly CPI report is released, and before the weeklong panic-driven run-down to the next month's release happens. You need to be very cautious about JPow (Jerome Powell) speeches and testimonies, FOMC meetings, and, to a lesser degree, monthly unemployment reports. A poor cluster of bank or other industry earnings releases could pose another challenge with regard to timing.
One more thing. Indicators are a pipe dream. All you need is price action and, secondarily, volume. People want some easy trading system based on technical analysis, but the truth is that technical analysis (specifically, support and resistance lines) only tell you what might happen, not what's likely to happen. If you want to make the strongest possible bet, you need a financially healthy company that's temporarily trading below its mean share price over a given period of time (more than one month), so that we can expect a regression to the mean, i.e. a move up. Ideally, you want a potent catalyst with a specific date. You also want the technicals to align with the fundamentals. Then, you want to see the share price trending up. You can be fooled into thinking that there's a one-day, or one-week, trend, but that's usually too short of a period to know that there's a real trend. At that point, buy some shares, see if the price keeps moving up, and buy some more. Scale in. But set stop losses and exit at the first sign of trouble. Even the very best traders who do this are wrong 50% of the time. They (we) make money by managing risk.
If you want to learn more, I'll give you one suggestion. Read the book, The Art and Science of Technical Analysis by Adam Grimes. There's a workbook that you can buy, too. That's not enough, because you still need to learn how to interpret data and calculate various ratios using the data on financial statements. The idea is to tilt the odds in your favor by making sure that many different factors align.
RSI and MACD will not help you to win trades. If it were that simple, no one would ever lose money. The trading journey involves learning macroeconomics, something about banking and finance, financial accounting to be able to understand and analyze financial statements, technical analysis, descriptive statistics (and how to use the R programming language), and portfolio theory. Different people are at different points in the learning journey. If you have any specific questions, feel free to private message me.
Good luck in your journey, and be careful.
Artem
Hi There,
I mostly sell puts that expire in several months. I prefer to run trades all the way to expiration, unless there's some very good reason to exit early. I don't really think about ITM or OTM, but where I think an underlying share price will be by the expiration date, based on close observation over many months. Sometimes that winds up being ITM, and other times, OTM.
You'll never be able to capture all of a move unless you run to expiration (and are right!), so don't worry about a price rising or dropping after you exit.
What problem have you been having? Can you give us specific examples?
To give you an idea, here are some of my plays:
-10 SKLZ 06/18 12.50 P: premium = $1,100
-20 SKLZ 07/19 15.00 P: premium = $2,600
-5 PLTR 08/20 20.00 P: premium = $1,100
-10 PLTR 08/20 22.00 P: premium = $2,600
-5 IMGN 06/18 8.00 C: premium = $119
-10 IMGN 10/15 5.00 P: premium = $1,000
-30 IMGN 10/15 6.00 P: premium = $4,200
-10 NVTA 09/17 35.00 P: premium = $6,100
-50 NNDM 11/19 7.50 P: premium = $8,600
-1 TDOC 10/15 150.00 P: premium = $1,475
-2 PACB 09/17 29.00 P: premium = $1,220
-1 FSLY 01/21 42.00 P: premium = $841
RKT IMGN ADM ADPT
Good luck! I would advise sticking to sectors you know will be huge: energy, cancer, dna, data, real estate. So much change and work to be done there the winners will be much more valuable in 10 years. Clearly do your own DD as I don’t know what I’m doing.
IMGN up 5%
IMGN lookin' good this morning.
Sold off my Imgn stock at a $2000 loss and said F it all in on GME. Another 30+ shares at $109 all in with 175 shares
lets go IMGN
IMGN$$$$
PUSH IMGN!!!
LETS GO my IMGN is doing AMAZING!
Any thoughts on Imgn stock advice appreciated.
lets go IMGN!
LOL my IMGN calls
IMGN go up and up and up!
lets go IMGN!
IMGN broke out buy now!
IMGN is boutta break for the high play
look at IMGN!
IMGN!
IMGN!!!!
LETS GO IMGN up so much!
IMGN going places!
GSAT, PFE, IMGN gonna explode next week!
IMGN!
IMGN hit 9.22 support!
PFE & IMGN on support levels!
IMGN hit support. BUY NOW!!!
lets go IMGN!
PLTR & IMGN
IMGN
IMGN buy now!!!
IMGN great buy get in before too late!
buy IMGN before market closes just hit support!!!
IMGN going to the MOON!
IMGN is a great buy!
My IMGN 2/19 calls are LOLing HARD at me today
IMGN is on discount right now. It will go back up within a few days
Well my IMGN calls are becoming worthless today.
$IMGN gonna rip after smashin earnings
$IMGN GANG LETS GO
$IMGN gang lets geddit
$IMGN gonna rip all day
Why $IMGN is gonna rip all day
https://www.zacks.com/stock/news/1263278/immunogen-imgn-q4-earnings-sales-top-pipeline-on-track
[https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html](https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html
$IMGN if you know you know....
$IMGN GANG STAND UPPP
IMGN GANG LETS EAT
$IMGN gang, if you know you know
IMGN MAKIN US TENDIES TMRW
WE LIKE $IMGN
$IMGN calls gonna print tmrw...Oh? Whats that? Some reasoning to go with it?
Immunogen $IMGN gonna make us fuggin rich this week
https://www.zacks.com/stock/news/1263278/immunogen-imgn-q4-earnings-sales-top-pipeline-on-track
https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html
Immunogen $IMGN gonna make us fuggin rich this week
https://www.zacks.com/stock/news/1263278/immunogen-imgn-q4-earnings-sales-top-pipeline-on-track
https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html
$IMGN going tits up tmrw
Immunogen $IMGN gonna make us fuggin rich this week
https://www.zacks.com/stock/news/1263278/immunogen-imgn-q4-earnings-sales-top-pipeline-on-track
https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html
Immunogen $IMGN gonna make us fuggin rich this week
​
https://www.zacks.com/stock/news/1263278/immunogen-imgn-q4-earnings-sales-top-pipeline-on-track
​
https://finance.yahoo.com/news/news-flash-analysts-just-made-042548468.html
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-bl-imgn-grpn-2021-02-12 $IMGN here we go baby
$IMGN calls gonna print, smashed earnings
$IMGN RIPPING
IMGN CALLS BEFORE CLOSE
IMGN CALLS BEFORE CLOSE
IMGN for long investment
IMGN is fuckin mooning
LFG BOYS IMGN IS FUCKIN MOONING
IMGN if u wanna wake up rich tuesday
IMGN if you dont wanna be poor anymore
IMGN make our pee pee hard gang
IMGN LFG BOYS
IMGN going to 15 by tuesday
IMGN LFG BOYS
IMGN boutta make the next leg up
Thougths on IMGN?
IMGN MOONING LFG BOYS GET ON THE WAVE
IMGN smashing earnings gonna have it running all day
IMGN to 15$ by next week
IMGN
IMGN HOLY FUCK YES.
IMGN MAKIN US RICH
IMGN
IMGN LETS FUCKIN GO
IMGN TO FUCKIN MARS
IMGN GANG
IMGN lets goo
IMGN so you can wake up happy tuesday
IMGN LFG
development stage biotechs never report meaningful income until they establish a revenue stream and your due diligence would have uncovered any potential income prior to the earnings call.
I wouldn't hang all of my money on any single investment and I'm speaking from experience. Holding big on IMGN
Imgn has my interest as well, heard their might be a spike in June but the only thing scheduled is the BLA, know if that’s enough to move the stock?
Imgn...someone knows something 🤐
Imagine being the type of person that says things like "America is a decaying empire".
Imagine.
IMaGiNe.
IMGN.
Interesting. Where do you see imgn stock being valued in 10 or 20 years?
I frequently pitch imgn . It is a cancer stock that has been beaten to death over the last 10+ years but are on the verge of a phase3 approval guided by the fda with the structure of their trial for a drug which was not approved the last time it was up for approval. The FDA saw the positivity in the results but were not able to approve without more test results.
End of 2021 should see atleast 1 approval for this company which would easily put it at 20 bucks but a take over could put it in the 10 bagger territory given the number of drugs in the pipeline.
Genentech uses imgn technology in their breast cancer drug
Imgn will be approved for a phase 3 drug at the end of 2021
GENE 7.5c 1/15and IMGN 10c 1/15 buy that shit 💯 is gonna 🚀🚀🚀🚀 let’s pump these up!!!
Imgn
It has already doubled this year look for another double next year
